| Literature DB >> 32485136 |
Lilianne Barbar1, Tanya Jain1, Matthew Zimmer1, Ilya Kruglikov1, Jessica S Sadick2, Minghui Wang3, Kriti Kalpana1, Indigo V L Rose2, Suzanne R Burstein1, Tomasz Rusielewicz1, Madhura Nijsure1, Kevin A Guttenplan4, Angelique di Domenico1, Gist Croft1, Bin Zhang3, Hiroko Nobuta5, Jean M Hébert5, Shane A Liddelow6, Valentina Fossati7.
Abstract
New methods for investigating human astrocytes are urgently needed, given their critical role in the central nervous system. Here we show that CD49f is a novel marker for human astrocytes, expressed in fetal and adult brains from healthy and diseased individuals. CD49f can be used to purify fetal astrocytes and human induced pluripotent stem cell (hiPSC)-derived astrocytes. We provide single-cell and bulk transcriptome analyses of CD49f+ hiPSC-astrocytes and demonstrate that they perform key astrocytic functions in vitro, including trophic support of neurons, glutamate uptake, and phagocytosis. Notably, CD49f+ hiPSC-astrocytes respond to inflammatory stimuli, acquiring an A1-like reactive state, in which they display impaired phagocytosis and glutamate uptake and fail to support neuronal maturation. Most importantly, we show that conditioned medium from human reactive A1-like astrocytes is toxic to human and rodent neurons. CD49f+ hiPSC-astrocytes are thus a valuable resource for investigating human astrocyte function and dysfunction in health and disease.Entities:
Keywords: A1 reactive astrocytes; CD49f; FACS purification; astrocytes; induced pluripotent stem cells; neurodegeneration; neurotoxicity
Mesh:
Substances:
Year: 2020 PMID: 32485136 PMCID: PMC8274549 DOI: 10.1016/j.neuron.2020.05.014
Source DB: PubMed Journal: Neuron ISSN: 0896-6273 Impact factor: 17.173